COMMUNIQUÉS West-GlobeNewswire

Resonant Inc. Names Michael Seifert as CFO
16/08/2018
- Seasoned Executive Brings More Than 25 Years Financial Experience - GOLETA, Calif., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Resonant, Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends [...]
Summit Awarded Additional $12 Million by BARDA for Phase 3 Development Programme of Ridinilazole for the Treatment of C. difficile Infection
16/08/2018
Brings Total Committed Funding Under BARDA Contract to $44 Million OXFORD, United Kingdom and CAMBRIDGE, Mass., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT, AIM:SUMM), a leader in antibiotic [...]
VBL Therapeutics Announces Second Quarter 2018 Financial Results
16/08/2018
Conference Call and Webcast at 8:30am Eastern Time Today VBL is well capitalized, cash sufficient for more than 3 years, beyond key inflection points VBL continues development of VB-111 for Ovarian Cancer with the OVAL [...]
Kamada Announces the End of the Labor Strike in the Company’s Manufacturing Facility; All Employees Returned to Work
16/08/2018
REHOVOT, Israel, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (Nasdaq: KMDA) (KMDA.TA), a plasma-derived protein therapeutics company, today announced that on August 15, 2018, the Company, the Employees’ Committee of [...]
Pain Therapeutics Announces $11.3 Million Registered Direct Offering Priced At-the-Market
16/08/2018
– Proceeds to Be Used for Drug Development, General Corporate Purpose – AUSTIN, Texas, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, today announced that it has [...]
HEXO Celebrates Five Years, 200 Employees … and Growing!
16/08/2018
GATINEAU, Quebec, Aug. 16, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“HEXO” or the “Company”) (TSX:HEXO) is proud to announce that it has reached two milestones this week. The Company is celebrating its [...]
HEXO célèbre cinq ans et 200 employés... et ça ne fait que commencer!
16/08/2018
GATINEAU, Québec, 16 août 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (« HEXO » ou la « Société ») (TSX:HEXO) est fière d’annoncer qu’elle a franchi deux étapes cette semaine. En effet, la Société célèbre son [...]
Clementia Announces Completion of Enrollment in Phase 3 MOVE Trial for FOP
16/08/2018
Enrollment Completed Four Months Ahead of Schedule; Two Interim Data Analyses On Track for 2019 MONTREAL, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ: CMTA), a clinical-stage company [...]
Clementia annonce l’achèvement du recrutement de l’essai MOVE, un essai de phase 3 pour la FOP
16/08/2018
Recrutement terminé quatre mois plus tôt que prévu; deux analyses des données intérimaires sont en préparation pour 2019 MONTRÉAL, 16 août 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ : CMTA), une [...]
CEPI Awards Contract Worth up to $36 million to Profectus BioSciences and Emergent BioSolutions to Develop Lassa Virus Vaccine
16/08/2018
OSLO, Norway, BALTIMORE and GAITHERSBURG, Md., Aug. 16, 2018 (GLOBE NEWSWIRE) -- CEPI (the Coalition for Epidemic Preparedness Innovations) today announced a new collaboration with Profectus BioSciences, Inc. and [...]
Treatment with ITB Therapy vs. Oral Medication Shows Quality of Life Improvement, Reduction in Spasticity-Related Pain
16/08/2018
Therapy Delivered via the Medtronic SynchroMed TM II Infusion System DUBLIN - August 16, 2018 - Medtronic plc (NYSE:MDT) today announced the online publication of 'Effect of intrathecal baclofen on pain and quality of [...]
Genetic Technologies Announces Proposed Joint Venture with Beijing Zishan Health Consultancy Limited
16/08/2018
MELBOURNE, Australia, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “ Company ”, “ GTG ”), a diversified molecular diagnostics company embracing blockchain technologies across [...]
Interim Report, Second Quarter 2018, BioPorto Group
16/08/2018
August 16, 2018 Announcement no. 14 BioPorto submits application to the FDA for clinical use of The NGAL Test™ in the US BioPorto completed the clinical studies for The NGAL Test™ in the second quarter of 2018 and has [...]
NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY - 30 JUNE 2018 (UNAUDITED)
16/08/2018
Company announcement, Helsinki, 16 August 2018 at 9:00 am NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY - 30 JUNE 201 8 (UNAUDITED) Highlights, January - June 2018 Nexstim delivered its first Navigated Brain Therapy (NBT [...]
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2018
16/08/2018
Message from the CEO The second quarter was dominated by extensive preparatory work relating to the pivotal phase III study, called “The Connection Study”. Our experience from the completed phase II study have [...]
Bavarian Nordic Announces First Half 2018 Results
16/08/2018
COPENHAGEN, Denmark, August 16, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results and business progress for the first half of 2018 and releases its financial calendar for [...]
H1 2018: Tecan posts strong increase in sales, driven by growth in the Partnering Business
16/08/2018
Financial results for the first half of 2018 Sales of CHF 273.5 million (H1 2017: CHF 252.2 million) Growth of 6.9% in local currencies or 8.4% in Swiss francs Strong growth in the Partnering Business Operating profit [...]
Tecan accelerates broad genomics strategy with the acquisition of NuGEN Technologies
16/08/2018
Acquisition of US-based NuGEN expands Tecan's dedicated solutions offering into new market segment of next-generation sequencing (NGS) reagents and increases overall recurring revenues NuGEN provides innovative NGS kits [...]
New Data for Fantom in Heart Attack Patients to be Presented at the TCT 2018 Conference
16/08/2018
SAN DIEGO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, will present new data on the use of the [...]

Pages